Showing results (41-50 of 162) with videos related to
Sort By:
Pageof 17
Haematologica|July 20, 2023
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myelomaYanmeng Wang, Catharina Muylaert, Arne Wyns, et al.Journal of Experimental & Clinical Cancer Research : CR|February 2, 2022
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesisInge Oudaert, Hatice Satilmis, Philip Vlummens, et al.Blood|July 28, 2005
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse modelEline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, et al.Oncotarget|April 30, 2016
The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potentialLiesbeth Bieghs, Hans E Johnsen, Ken Maes, et al.Blood Cancer Journal|November 20, 2019
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphomaAnke Maes, Ken Maes, Philip Vlummens, et al.Oncotarget|February 12, 2015
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myelomaKen Maes, Eva De Smedt, Alboukadel Kassambara, et al.Cancer Research|June 18, 2009
Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myelomaSarah Deleu, Miguel Lemaire, Janine Arts, et al.Cancer Letters|April 23, 2016
Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activityKim De Veirman, Jinheng Wang, Song Xu, et al.Haematologica|October 17, 2009
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myelomaJo Caers, Dirk Hose, Ine Kuipers, et al.Cancers|July 1, 2014
Cancer associated fibroblasts and tumor growth: focus on multiple myelomaKim De Veirman, Luigia Rao, Elke De Bruyne, et al.Pageof 17